Literature DB >> 28204853

[Optimized detection and characterization of liver metastases : The role of current MRI contrast agents].

J M Weinrich1, L Well1, P Bannas2.   

Abstract

Metastases are the most common malignant lesions of the liver. The presence of liver metastases is an important prognostic factor and is decisive for the further management, especially in patients with colorectal cancer. Detection and characterization of liver metastases as well as differentiation from benign lesions are of high importance and a daily challenge in clinical radiology. Contrast-enhanced magnetic resonance imaging (MRI) has the highest sensitivity in detecting liver metastases. The sensitivity of MRI has been further increased due to the development of liver-specific contrast agents. This article describes the role of extracellular and hepatobiliary contrast agents for the detection and characterization of liver metastases. Moreover, the current knowledge on safety, sequence optimization, transient severe dyspnea and the combination of hepatobiliary with intravascular contrast agents for liver imaging is discussed.

Entities:  

Keywords:  Liver imaging; Prognosis; Sequence optimization; Treatment protocols; Tumor patients

Mesh:

Substances:

Year:  2017        PMID: 28204853     DOI: 10.1007/s00117-017-0214-2

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  37 in total

1.  Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.

Authors:  Alexander Radbruch; Lukas D Weberling; Pascal J Kieslich; Oliver Eidel; Sina Burth; Philipp Kickingereder; Sabine Heiland; Wolfgang Wick; Heinz-Peter Schlemmer; Martin Bendszus
Journal:  Radiology       Date:  2015-04-06       Impact factor: 11.105

2.  Influence of Gadoxetate Disodium on Oxygen Saturation and Heart Rate during Dynamic Contrast-enhanced MR Imaging.

Authors:  Tatsuya Hayashi; Satoshi Saitoh; Yoshinori Tsuji; Junji Takahashi; Naomi Tagaya; Mariko Hiramoto; Kei Fukuzawa; Masakatsu Tano; Tosiaki Miyati; Hiromitsu Kumada
Journal:  Radiology       Date:  2015-03-26       Impact factor: 11.105

3.  An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging.

Authors:  Utaroh Motosugi; Peter Bannas; Candice A Bookwalter; Katsuhiro Sano; Scott B Reeder
Journal:  Radiology       Date:  2015-10-16       Impact factor: 11.105

Review 4.  Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver.

Authors:  Irene Cruite; Michael Schroeder; Elmar M Merkle; Claude B Sirlin
Journal:  AJR Am J Roentgenol       Date:  2010-07       Impact factor: 3.959

5.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

Authors:  Azusa Kitao; Yoh Zen; Osamu Matsui; Toshifumi Gabata; Satoshi Kobayashi; Wataru Koda; Kazuto Kozaka; Norihide Yoneda; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

Review 6.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

Authors:  Christoph J Zech; Karin A Herrmann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

Review 7.  Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.

Authors:  Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Marie-France Bellin; Michele Bertolotto; Georg Bongartz; Olivier Clement; Peter Leander; Gertraud Heinz-Peer; Peter Reimer; Fulvio Stacul; Aart van der Molen; Judith A W Webb
Journal:  Eur Radiol       Date:  2012-08-04       Impact factor: 5.315

8.  Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.

Authors:  Hye Jin Kim; Seung Soo Lee; Jae Ho Byun; Jin Cheon Kim; Chang Sik Yu; Seong Ho Park; Ah Young Kim; Hyun Kwon Ha
Journal:  Radiology       Date:  2014-10-03       Impact factor: 11.105

9.  Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.

Authors:  Christoph J Zech; Nahila Justo; Andrea Lang; Ahmed Ba-Ssalamah; Myeong-Jin Kim; Harald Rinde; Eduard Jonas
Journal:  Eur Radiol       Date:  2016-02-24       Impact factor: 5.315

10.  Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases.

Authors:  C J Zech; P Korpraphong; A Huppertz; T Denecke; M J Kim; W Tanomkiat; E Jonas; A Ba-Ssalamah
Journal:  Br J Surg       Date:  2014-03-20       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.